| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 23.646 | 33.998 | 37.155 | 77.628 | 101.831 |
| Total Income - EUR | - | - | - | - | - | 27.781 | 34.004 | 37.155 | 77.629 | 101.833 |
| Total Expenses - EUR | - | - | - | - | - | 26.238 | 32.232 | 34.789 | 44.874 | 50.700 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.543 | 1.772 | 2.366 | 32.755 | 51.133 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.397 | 1.548 | 2.050 | 32.018 | 48.139 |
| Employees | - | - | - | - | - | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr.emese Medfam S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 3.044 | 16.823 | 13.514 | 10.278 | 6.962 |
| Current Assets | - | - | - | - | - | 4.534 | 4.910 | 5.848 | 25.962 | 57.092 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.645 | 3.006 | 2.832 | 12.377 | 31.179 |
| Cash | - | - | - | - | - | 2.889 | 1.904 | 3.016 | 13.584 | 25.913 |
| Shareholders Funds | - | - | - | - | - | 1.438 | 2.954 | 5.014 | 33.062 | 48.187 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 6.139 | 18.779 | 14.348 | 3.178 | 15.888 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr.emese Medfam S.r.l.